The mechanisms involved in its anti-cancer activity are still being elucidated, but evidence suggests that it inhibits proteasome degradation of IκB, an inhibitor of nuclear factor-κB (NF-κB) in the cancer cell [13–16]. This evidence concerns the gene NFKB1 and cancer.